Soluble thrombomodulin activity and soluble thrombomodulin antigen in plasma

Journal of Thrombosis and Haemostasis

Volumn 3, Issue 5, 2005, Pages 976-982

  Öhlin, Ann Kristin ^a   Larsson, K ^a   Hansson, M ^a  

^a LUND UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Anticoagulant activity; Protein C pathway; Thrombomodulin

Indexed keywords

PROTEIN C; THROMBOMODULIN; ANTIGEN; MONOCLONAL ANTIBODY;

ANTICOAGULATION; ANTIGEN BINDING; ARTICLE; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; HUMAN EXPERIMENT; HUMAN TISSUE; IMMOBILIZATION; IMMUNOASSAY; MALE; NORMAL HUMAN; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN FUNCTION; ADOLESCENT; ADULT; AGED; BLOOD; BLOOD CLOTTING; BLOOD CLOTTING TEST; CHEMISTRY; IMMUNOLOGY; INFLAMMATION; ISCHEMIA; KINETICS; METHODOLOGY; MIDDLE AGED; MUTATION; REFERENCE VALUE; SENSITIVITY AND SPECIFICITY; SEROLOGY; SEX DIFFERENCE;

ADOLESCENT; ADULT; AGED; ANTIBODIES, MONOCLONAL; ANTIGENS; BLOOD COAGULATION; BLOOD COAGULATION TESTS; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; INFLAMMATION; ISCHEMIA; KINETICS; MALE; MIDDLE AGED; MUTATION; PROTEIN C; REFERENCE VALUES; SENSITIVITY AND SPECIFICITY; SEROLOGIC TESTS; SEX FACTORS; THROMBOMODULIN;

EID: 23844451164     PISSN: 15387933     EISSN: 15387836     Source Type: Journal    
DOI: 10.1111/j.1538-7836.2005.01267.x     Document Type: Article

References (24)

1. Esmon CT, Fukudome K, Mather T, Bode W, Regan LM, Stearns-Kurosawa DJ, Kurosawa S. Inflammation, sepsis, and coagulation. Haematologica 1999; 84: 254-9.
2. Esmon CT. Thrombomodulin as a model of molecular mechanisms that modulate protease specificity and function at the vessel surface. Faseb J 1995; 9: 946-55.
3. Bajzar L, Morser J, Nesheim M. TAFI, or plasma procarboxypeptidase B, couples the coagulation and fibrinolytic cascades through the thrombin-thrombomodulin complex. J Biol Chem 1996; 271: 16603-8.
4. Bajzar L, Nesheim M, Morser J, Tracy PB. Both cellular and soluble forms of thrombomodulin inhibit fibrinolysis by potentiating the activation of thrombin-activable fibrinolysis inhibitor. J Biol Chem 1998; 273: 2792-8.
5. Ishii H, Majerus PW. Thrombomodulin is present in human plasma and urine. J Clin Invest 1985; 76: 2178-81.
6. Conway EM, Nowakowski B. Biologically active thrombomodulin is synthesized by adherent synovial fluid cells and is elevated in synovial fluid of patients with rheumatoid arthritis. Blood 1993; 81: 726-33.
7. Hosaka Y, Takahashi Y, Ishii H. Thrombomodulin in human plasma contributes to inhibit fibrinolysis through acceleration of thrombin-dependent activation of plasma procarboxypeptidase B. Thromb Haemost 1998; 79: 371-7.
8. Uehara S, Gotoh K, Handa H. Separation and characterization of the molecular species of thrombomodulin in the plasma of diabetic patients. Thromb Res 2001; 104: 325-32.
9. Takahashi Y, Hosaka Y, Imada K, Adachi T, Niina H, Mochizuki H. Species specificity of the anticoagulant activity of human urinary soluble thrombomodulin. Thromb Res 1998; 89: 187-97.
10. Takano S, Kimura S, Ohdama S, Aoki N. Plasma thrombomodulin in health and diseases. Blood 1990; 76: 2024-9.
11. Ishii H, Nakano M, Tsubouchi J, Ishikawa T, Uchiyama H, Hiraishi S, Tahara C, Miyajima Y, Kazama M. Establishment of enzyme immunoassay of human thrombomodulin in plasma and urine using monoclonal antibodies. Thromb Haemost 1990; 63: 157-62.
12. Ohlin AK, Morser J, Ohlin H. Soluble thrombomodulin antigen in plasma is increased in patients with acute myocardial infarction treated with thrombolytic therapy. Thromb Res 1996; 82: 313-22.
13. Clarke JH, Light DR, Blasko E, Parkinson JF, Nagashima M, McLean K, Vilander L, Andrews WH, Morser J, Glaser CB. The short loop between epidermal growth factor-like domains 4 and 5 is critical for human thrombomodulin function. J Biol Chem 1993; 268: 6309-15.
14. Glaser CB, Morser J, Clarke JH, Blasko E, McLean K, Kuhn I, Chang RJ, Lin JH, Vilander L, Andrews WH, Light DR. Oxidation of a specific methionine in thrombomodulin by activated neutrophil products blocks cofactor activity. A potential rapid mechanism for modulation of coagulation. J Clin Invest 1992; 90: 2565-73.
15. Lundblad RL, Uhteg LC, Vogel CN, Kingdon HS, Mann KG. Preparation and partial characterization of two forms of bovine thrombin. Biochem Biophys Res Commun 1975; 66: 482-9.
16. Owen WG, Jackson CM. Activation of prothrombin with Oxyuranus scutellatus scutellatus (Taipan snake) venom. Thromb Res 1973; 3: 705-14.
17. 2+ binding and biological activity. J Biol Chem 1988; 263: 19240-8.
18. Nilsson TK, Hellsten G, Amiral J. Plasma thrombomodulin concentrations in relation to cardiovascular risk factors in a population sample. Blood Coagul Fibrinolysis 1993; 4: 455-8.
19. Jansson JH, Boman K, Brannstrom M, Nilsson TK. High concentration of thrombomodulin in plasma is associated with hemorrhage: a prospective study in patients receiving long-term anticoagulant treatment. Circulation 1997; 96: 2938-43.
20. Henriksson AE, Nilsson TK, Bergqvist D. Thrombomodulin and acute bleeding duodenal ulcer. J Intern Med 1999; 246: 421-2.
21. Salomaa V, Matei C, Aleksic N, Sansores-Garcia L, Folsom AR, Juneja H, Chambless LE, Wu KK. Soluble thrombomodulin as a predictor of incident coronary heart disease and symptomless carotid artery atherosclerosis in the Atherosclerosis Risk in Communities (ARIC) Study: a case-cohort study. Lancet 1999; 353: 1729-34.
22. Aleksic N, Folsom AR, Cushman M, Heckbert SR, Tsai MY, Wu KK. Prospective study of the A455V polymorphism in the thrombomodulin gene, plasma thrombomodulin, and incidence of venous thromboembolism: the LITE Study. J Thromb Haemost 2003; 1: 88-94.
23. Conway EM, Van de Wouwer M, Pollefeyt S, Jurk K, Van Aken H, De Vriese A, Weitz JI, Weiler H, Hellings PW, Schaeffer P, Herbert JM, Collen D, Theilmeier G. The lectin-like domain of thrombo-modulin confers protection from neutrophil-mediated tissue damage by suppressing adhesion molecule expression via nuclear factor kappaB and mitogen-activated protein kinase pathways. J Exp Med 2002; 196: 565-77.
24. Weiler H, Isermann BH. Thrombomodulin. J Thromb Haemost 2003; 1: 515-24.